SMA Awareness Month: Thank you for helping us spread the word August 31, 2017 This month, we've had the pleasure of working with the Bessey family and the Hearts for Ezra Foundation to raise awareness for spinal muscular atrophy (SMA). Th... Continue Reading
Raising Awareness for Spinal Muscular Atrophy: Q&A with Emily Bessey of Hearts for Ezra August 23, 2017 Q&A with Shivani Nazareth, MS, CGC, Director of Medical Affairs, Counsyl August is SMA Awareness Month. If you’re unfamiliar with SMA (spinal muscular at... Continue Reading
Spinal Muscular Atrophy: Are you 1 in 50? August 17, 2017 This month, we are striving to bring awareness to spinal muscular atrophy (SMA), a serious inherited condition caused by changes in the SMN1 gene, which control... Continue Reading
Clinical Consequences of NIPS No-Calls: Methodology Matters July 26, 2017 5 questions with our webinar speakers Last week, in a 30 minute live webinar, authors of a recent study in Prenatal Diagnosis discussed the key differences betw... Continue Reading
The next evolution of carrier screening: Foresight™ Carrier Screen June 28, 2017 We are excited to announce industry-leading improvements to our flagship carrier screening test as well as new names for all of our genetic screens, on Wednesda... Continue Reading
Say hello to our new product names June 28, 2017 We are excited to announce new names for all of our genetic screens as well as industry-leading improvements to our flagship carrier screening test. Introducing... Continue Reading
Counsyl Insights: Non-invasive prenatal screening at low fetal fraction (Video) June 13, 2017 Introducing the Counsyl Insights video series At Counsyl, we are committed to sharing data with the scientific and medical communities. That’s why we are exc... Continue Reading
Introducing Counsyl’s New Sample Tracker for Genetic Tests June 7, 2017 Convenient, real-time access to sample status for patients and healthcare providers Now patients and healthcare providers can access real-time status of any Cou... Continue Reading
Realizing the full potential of inherited cancer screening May 23, 2017 by James Goldberg, MD, Counsyl Chief Medical Officer One of our most powerful weapons in the fight against cancer - genetic testing - remains greatly underused... Continue Reading
ACOG recognizes expanded carrier screening as an acceptable strategy for carrier screening March 2, 2017 by James Goldberg, MD, Counsyl Chief Medical Officer Back in 2010, The New York Times reported that Counsyl was bringing genetic tests to the masses. We were a ... Continue Reading
Expanded carrier screening: A review of growing consensus February 27, 2016 5 questions with the lead author Shivani Nazareth, Director of Women’s Health at Counsyl, sits down with lead author and VP of Clinical Specialists at Counsy... Continue Reading
Transparency in non-invasive prenatal screening (NIPS) results reporting February 23, 2016 Individualized PPV and why it matters 5 Questions with Dr. James Goldberg, FACOG, FACMG 1. What is Positive Predictive Value (PPV)? Dr. Goldberg: Positi... Continue Reading
How design is driving change in healthcare January 11, 2016 Designing for healthcare can force you to rethink everything you thought you knew about how people behave. The industry’s dense thicket of lawyers, privacy r... Continue Reading
Counsyl Appoints Ted Snelgrove as Chief Business Officer January 8, 2016 SAN FRANCISCO--(BUSINESS WIRE)--Counsyl, a health technology company that offers DNA testing for diseases that can impact men, women and their children, today... Continue Reading
World Technology Summit Awards Counsyl for Innovation in Health & Medicine November 25, 2015 What do 3-D printing of soft tissues, space travel to Pluto and population screening for rare diseases have in common? One word: innovation. Last week in New Yo... Continue Reading